Top Fully Remote Pharmaceutical Companies (13)
At Inato, we’re on a mission to accelerate the pace of medical innovation by bringing clinical research to each and every patient, regardless of who they are and where they live. Our platform, made to connect community-based research centers to trials across the globe, aims to create greater visibility, access, and engagement across a more diverse population of doctors and their patients.
.jpg)
Drp IV is a mobile IV therapy company servicing Utah, Salt Lake, Davis, Weber, and Summit counties. We bring IV Therapy right to your doorstep so you can get hydrated and feeling better without needing to leave your home! Recovery from sickness, boost athletic performance, and start feeling like the best version of yourself today! Call or text 385-301-6279
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of transformational therapies for autoimmune diseases. We are leveraging the extensive drug development expertise of our team to acquire best-in-class assets against compelling targets, and applying them to disease areas with significant unmet need. Timberlyne’s lead program, CM313, is an IgG1 monoclonal antibody with enhanced complement-dependent cytotoxicity that targets CD38. By targeting CD38, highly expressed on plasma cells, NK cells, and other immune cells, CM313 can modulate multiple arms of the immune system leading to both rapid and durable responses across a range of autoimmune diseases. CM313 has been tested in numerous disease states including Immune Thrombocytopenia, Systemic Lupus Erythematosus, and relapsed/refractory Multiple Myeloma. Timberlyne plans to develop CM313 across a broad range of autoimmune indications. Launched in 2024, Timberlyne has raised $180 million from leading life sciences investors.
Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. At Avadel, our core values foster an atmosphere of innovation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with narcolepsy. Learn more about us at www.avadel.com and follow us on Twitter at @AvadelPharma.
Maisha Meds has created the first and largest network of private pharmacies and clinics in East Africa through a mobile app that delivers subsidized care. Not only does the app now help over 3,500 businesses operate by making sales, managing inventory, and tracking patients; it also reimburses them for providing affordable care to patients for malaria, birth control, and HIV prevention. By harnessing the power of a vast but fragmented private sector, our program improves access for patients, supports pharmacies that often serve as a first point of contact, and generates vital research and data on global health and market trends.
Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more information please visit https://www.rivuspharma.com/
ALCON INDUSTRIES is a quality pharmaceutical product manufacturer with over 30 years of successfull presence in Indian Pharma industry. Alcon manufactures & markets a variety of Pharmaceutical formulations. It specialises in Liquid oral and Suspension formulations. Alcon is certified for ISO 9001-2008 quality standards by NQAQSR. It is designed, developed as per the World Health Organization (WHO) standards.
.png)
We are among the best and most reliable pharmacies in the USA. Our team is dedicated to providing its consumers with high-quality products and services. We offer a wide range of pharmaceuticals and healthcare products, including prescription drugs. You can also acquire our products easily online.
IMPACT is a Contract Research Organization (CRO) in Research Triangle Park, NC that specializes in the following services: • Medical writing and quality control • Drug development consulting • Regulatory affairs • Regulatory operations • Project and program management • Early-phase clinical trial management At IMPACT, our people are our biggest strength. Our experts are highly-trained drug-development professionals who are passionate about helping each client get their drug to market. Each employee at IMPACT embodies our core values of quality, integrity, flexibility, and responsiveness. Our goal is to produce high-quality, scientifically-sound deliverables for every client on every project. Our experienced personnel and our honest, transparent, and flexible approach have led to trusted, lasting relationships with our clients, who consider us as an extension of their project teams . Whether you are a potential client or a prospective employee, our team at IMPACT looks forward to working with you!
Curza is a small molecule therapeutics development company. Curza has developed a new class of antibiotics that are active and selective against Gram-negative pathogens.
ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. With a deep and global network, ArriVent seeks to access unique and best-in-class drug candidates at various development stages, including those coming from China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, ArriVent aims to globalize medicines for patients with unmet medical need in a broad range of diseases, with an initial focus in oncology.
Motitus is a consulting firm specializing in biotechnology, pharmaceuticals, healthcare, life sciences, and health tech, working with ambitious leaders. We bridge the gap between thinking and implementation with extraordinary impact. We deliver mission projects that transform your business into state-of-the-art for the industry. The word Motitus carries a compelling narrative that resonates deeply within the realms of healthcare and innovation. The name itself, derived from the Latin word for "movement," encapsulates the essence of progress, dynamism, and transformation—qualities that are vital in the fast-evolving landscape of health and medicine. From its inception, Motitus aimed to be more than just a consultancy; it sought to be a catalyst for change. The brand's identity is built around the concept of movement, representing the fluidity and adaptability required in modern healthcare. Whether it’s helping a pharmaceutical company navigate regulatory hurdles or assisting a biotech startup in bringing its product to market, Motitus embodies the spirit of progress and agility.
BioReact leverages the power of artificial intelligence and machine learning to help with design of experiment (DOE) and optimizing the parameters to help your cells reach their full potential.
Work Your Passion. Live Your Purpose.
